Skip to main content
Premium Trial:

Request an Annual Quote

PamGene Gets $2.7M in Dutch Grants, Collaborates on Two Studies

NEW YORK, March 9 (GenomeWeb News) - PamGene, a Dutch DNA chip provider, has secured €2 million ($2.7) million in grant money from the Dutch government, the company said today.

The funding was made available through SenterNovem, a government agency. PamGene said it will use the cash to help it develop systems biology and bioinformatics applications on its PamGene array platform.

The company also revealed that it is a participant in the European Union's 6th Framework Programme through an approved project that seeks to develop a rapid molecular diagnostic for mitochondrial diseases. Partners include the Netherlands Proteomics Centre, the University of Maastricht, and others.

PamGene will also be collaborating with the Netherlands Proteomics Centre to improve protemics research tools and to aid its mission of achieving functional proteomics capabilities.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.